Berlin - Delayed Quote EUR
AbbVie Inc (4AB.BE)
169.00
-2.40
(-1.40%)
As of 7:35:06 PM GMT+2. Market Open.
Loading Chart for 4AB.BE
- Previous Close
171.40 - Open
170.40 - Bid 168.40 x --
- Ask 170.40 x --
- Day's Range
166.80 - 171.40 - 52 Week Range
141.86 - 203.80 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 23, 2025 - Jul 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4AB.BE
View MorePerformance Overview: 4AB.BE
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
4AB.BE
1.62%
S&P 500 (^GSPC)
0.28%
1-Year Return
4AB.BE
17.40%
S&P 500 (^GSPC)
12.96%
3-Year Return
4AB.BE
29.29%
S&P 500 (^GSPC)
46.57%
5-Year Return
4AB.BE
163.87%
S&P 500 (^GSPC)
109.15%
Compare To: 4AB.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
48.20
+3.05%
Mkt Cap 103.623B
Industry Drug Manufacturers—General
Mkt Cap undefined -
Industry -
Statistics: 4AB.BE
View MoreValuation Measures
As of 5/12/2025
Market Cap
299.00B
Enterprise Value
356.63B
Trailing P/E
82.25
Forward P/E
15.85
PEG Ratio (5yr expected)
0.41
Price/Sales (ttm)
5.95
Price/Book (mrq)
239.41
Enterprise Value/Revenue
6.98
Enterprise Value/EBITDA
27.02
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: 4AB.BE
View MoreCompany Insights: 4AB.BE
Research Reports: 4AB.BE
View MorePeople Also Watch
4AB.F AbbVie Inc.
167.00
-2.00%
4AB.MU AbbVie Inc
170.20
+5.71%
ABBV.MX AbbVie Inc.
3,664.12
-2.32%
4AB.SG AbbVie Inc
168.80
+5.37%
MRK.VI Merck & Co., Inc.
69.30
-3.21%
4AB.DE AbbVie Inc.
168.20
-2.55%
ABBV34.SA AbbVie Inc.
65.94
-2.71%
AMG.F Amgen Inc.
246.65
+7.10%
0QCV.IL AbbVie Inc.
186.50
-1.32%
BMYMP Bristol-Myers Squibb Company PFD CONV 2
831.56
0.00%
4AB.DU AbbVie Inc
168.80
-2.43%
LLY.DU Eli Lilly and Co
667.20
-2.84%
LLY.MU Eli Lilly and Co
667.60
+4.41%
AMGN34.SA Amgen Inc.
55.31
+2.33%
0Q1N.IL Pfizer Inc.
22.80
-0.55%
PFE.BE Pfizer Inc
20.50
-1.35%